Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Melissa L. Cate"'
Autor:
Hong M. Moulton, Jed N. Hassinger, Derek S. Youngblood, Patrick L. Iversen, Muralimohan T. Reddy, Melissa L. Cate, Tom Whitehead, Adams Amantana
Publikováno v:
Bioconjugate Chemistry. 18:1325-1331
Conjugation of arginine-rich cell-penetrating peptide (CPP) to phosphorodiamidate morpholino oligomers (PMO) has been shown to enhance cytosolic and nuclear delivery of PMO. However, the in vivo disposition of CPP-PMO is largely unknown. In this stud
Publikováno v:
Drug Metabolism and Disposition. 30:757-762
Antisense phosphorodiamidate morpholino oligomers (PMO) inhibit targeted gene expression by preventing ribosomal assembly, thus preventing translation. Inhibition of cytochrome P450 (P450) 3A4 expression was examined in primary human hepatocytes from
Autor:
William M. Baird, Miriam C. Poirier, Melissa L. Cate, Laura J. Schild, Ainsley Weston, Brinda Mahadevan, Channa Keshava, Patrick L. Iversen, Vikram Arora, Clifford B. Pereira
Publikováno v:
Molecular carcinogenesis. 45(2)
Tamoxifen (TAM) is widely used in the treatment and prevention of breast cancer. There is clear evidence that cytochrome P450 (CYP) 3A enzymes play an important role in TAM metabolism, resulting in metabolites that lead to formation of TAM–DNA addu
Autor:
Adams Amantana, Hong M. Moulton, Melissa L. Cate, Muralimohan T. Reddy, Tom Whitehead, Jed N. Hassinger, Derek S. Youngblood, Patrick L. Iversen
Publikováno v:
Bioconjugate Chemistry; Jul2007, Vol. 18 Issue 4, p1325-1331, 7p
Autor:
Brinda Mahadevan, Vikram Arora, Laura J. Schild, Channa Keshava, Melissa L. Cate, Patrick L. Iversen, Miriam C. Poirier, Ainsley Weston, Clifford Pereira, William M. Baird
Publikováno v:
Molecular Carcinogenesis; Feb2006, Vol. 45 Issue 2, p118-125, 8p